These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 7475833

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bronchoscopically administered recombinant human DNase for lobar atelectasis in cystic fibrosis.
    Slattery DM, Waltz DA, Denham B, O'Mahony M, Greally P.
    Pediatr Pulmonol; 2001 May; 31(5):383-8. PubMed ID: 11340685
    [Abstract] [Full Text] [Related]

  • 5. Easy removal of a large mucus plug with a flexible paediatric bronchoscope after administration of rhDNase (Pulmozyme).
    Kamin W, Klär-Hlawatsch B, Truebel H.
    Klin Padiatr; 2006 May; 218(2):88-91. PubMed ID: 16506110
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
    Coates AL.
    J Pediatr; 2001 Dec; 139(6):768-70. PubMed ID: 11743499
    [No Abstract] [Full Text] [Related]

  • 8. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability.
    Wills PJ, Wodehouse T, Corkery K, Mallon K, Wilson R, Cole PJ.
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):413-7. PubMed ID: 8756815
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. USAN Council. List No.405. New names. Dornase alfa.
    Clin Pharmacol Ther; 1998 Jun; 63(6):705. PubMed ID: 9687230
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dornase alfa approved for use by cystic fibrosis patients.
    Am J Hosp Pharm; 1994 Apr 01; 51(7):869-70. PubMed ID: 8017432
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.
    Spencer DA.
    Thorax; 1997 Apr 01; 52 Suppl 2(Suppl 2):S89-91. PubMed ID: 9155860
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. New treatment for cystic fibrosis.
    Kuhn RJ.
    Am Pharm; 1994 Feb 01; NS34(2):16-8. PubMed ID: 8166040
    [No Abstract] [Full Text] [Related]

  • 18. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis.
    Merkus PJ, de Hoog M, van Gent R, de Jongste JC.
    Eur Respir J; 2001 Oct 01; 18(4):734-7. PubMed ID: 11716180
    [Abstract] [Full Text] [Related]

  • 19. Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.
    Conway SP, Watson A.
    Thorax; 1997 Apr 01; 52 Suppl 2(Suppl 2):S64-8. PubMed ID: 9155855
    [No Abstract] [Full Text] [Related]

  • 20. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
    Deacon J, Abdelghany SM, Quinn DJ, Schmid D, Megaw J, Donnelly RF, Jones DS, Kissenpfennig A, Elborn JS, Gilmore BF, Taggart CC, Scott CJ.
    J Control Release; 2015 Jan 28; 198():55-61. PubMed ID: 25481442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.